• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活体供体空腹血糖水平低与肝移植受体移植物丢失风险之间的关联。

Association between low fasting glucose of the living donor and risk of graft loss in the recipient after liver transplantation.

作者信息

Koh Hwa-Hee, Lee Minyoung, Kang Minyu, Yim Seung Hyuk, Choi Mun Chae, Min Eun-Ki, Lee Jae Geun, Joo Dong Jin, Kim Myoung Soo, Lee Jae Seung, Kim Deok-Gie

机构信息

Department of Surgery, Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, South Korea.

Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.

出版信息

Sci Rep. 2025 Jan 6;15(1):951. doi: 10.1038/s41598-024-80604-x.

DOI:10.1038/s41598-024-80604-x
PMID:39762289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11704233/
Abstract

Several donor-specific factors influence the functional recovery and long-term outcomes of liver grafts. This study investigated the association between donor fasting glucose (DFG) and recipient outcomes after living donor liver transplantation (LDLT) in 950 cases at a single center. Patients were divided into two groups: low-DFG (< 85 mg/dL, n = 120) and control (≥ 85 mg/dL, n = 830). The five-year graft survival rate was significantly lower in the low-DFG group (71.5%) compared to the control group (80.0%) (P = 0.02). Multivariable Cox regression analysis showed that low DFG was independently associated with graft loss (hazard ratio 1.72, 95% CI 1.15-2.56, P = 0.008). In propensity score-matched groups, the low-DFG group also had lower survival rates (71% vs. 83.1%, P = 0.004). The presence of additional risk factors, such as low graft-to-recipient weight ratio, older donor age, and longer cold ischemic time, further reduced graft survival in the low-DFG group. A DFG level < 85 mg/dL is associated with higher risk of graft failure after LDLT, especially when combined with other risk factors. Low DFG should be considered a prognostic marker in LDLT planning, with potential to improve patient outcomes as further research clarifies the underlying pathophysiological mechanisms.

摘要

几种供体特异性因素会影响肝移植移植物的功能恢复和长期预后。本研究调查了单中心950例活体肝移植(LDLT)受者中供体空腹血糖(DFG)与受者预后之间的关联。患者被分为两组:低DFG组(<85mg/dL,n = 120)和对照组(≥85mg/dL,n = 830)。低DFG组的五年移植物存活率(71.5%)显著低于对照组(80.0%)(P = 0.02)。多变量Cox回归分析显示,低DFG与移植物丢失独立相关(风险比1.72,95%CI 1.15 - 2.56,P = 0.008)。在倾向评分匹配组中,低DFG组的存活率也较低(71%对83.1%,P = 0.004)。存在其他风险因素,如低移植物与受者体重比、供体年龄较大和冷缺血时间较长,会进一步降低低DFG组的移植物存活率。DFG水平<85mg/dL与LDLT后移植物失败的较高风险相关,尤其是与其他风险因素合并存在时。在LDLT规划中,低DFG应被视为一种预后标志物,随着进一步研究阐明潜在的病理生理机制,有可能改善患者预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3630/11704233/7898ffe05d4b/41598_2024_80604_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3630/11704233/603f2d4885fe/41598_2024_80604_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3630/11704233/a60d9e4d7e86/41598_2024_80604_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3630/11704233/7898ffe05d4b/41598_2024_80604_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3630/11704233/603f2d4885fe/41598_2024_80604_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3630/11704233/a60d9e4d7e86/41598_2024_80604_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3630/11704233/7898ffe05d4b/41598_2024_80604_Fig3_HTML.jpg

相似文献

1
Association between low fasting glucose of the living donor and risk of graft loss in the recipient after liver transplantation.活体供体空腹血糖水平低与肝移植受体移植物丢失风险之间的关联。
Sci Rep. 2025 Jan 6;15(1):951. doi: 10.1038/s41598-024-80604-x.
2
Defining long-term outcomes with living donor liver transplantation in North America.界定北美活体供肝移植的长期预后。
Ann Surg. 2015 Sep;262(3):465-75; discussion 473-5. doi: 10.1097/SLA.0000000000001383.
3
A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.肝移植供体与受体重比小于 0.8 不能排除成人-成人右半活体肝移植。
Liver Transpl. 2009 Dec;15(12):1776-82. doi: 10.1002/lt.21955.
4
Effect of donor age on graft function and long-term survival of recipients undergoing living donor liver transplantation.供体年龄对接受活体供肝移植受者移植物功能及长期生存的影响。
Hepatobiliary Pancreat Dis Int. 2015 Feb;14(1):50-5. doi: 10.1016/s1499-3872(15)60334-4.
5
Outcomes of living donor liver transplant recipients receiving grafts with the graft-to-recipient weight ratio less than 0.6%: A matched pair analysis.供体与受体体重比小于 0.6%的活体肝移植受者的预后:配对分析。
Liver Transpl. 2024 May 1;30(5):519-529. doi: 10.1097/LVT.0000000000000276. Epub 2023 Oct 4.
6
Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.活体捐赠与循环死亡后肝脏移植在低终末期肝病模型受体中的比较。
Liver Transpl. 2019 Apr;25(4):580-587. doi: 10.1002/lt.25073. Epub 2019 Mar 6.
7
Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in Children.活体供肝肝移植在儿童中具有持久的临床和免疫优势。
Transplantation. 2018 Jun;102(6):953-960. doi: 10.1097/TP.0000000000002110.
8
Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.1996 - 2011年东京大学活体供肝肝移植:HLA配型和阳性交叉配型对长期生存及免疫耐受的影响
Clin Transpl. 2011:223-35.
9
Outcomes and Risk Factors for Liver Transplantation Using Graft-to-Recipient Weight Ratio Less Than 0.8 Graft From Living Donors: Multicentric Cohort Study.使用来自活体供者的移植物与受者体重比小于 0.8 的移植物进行肝移植的结果和风险因素:多中心队列研究。
Ann Surg. 2024 Jun 1;279(6):1018-1024. doi: 10.1097/SLA.0000000000006104. Epub 2023 Sep 27.
10
Improved outcomes of ABO-incompatible living donor liver transplant with biologically related donors.与生物相关供者进行 ABO 血型不相容活体肝移植可改善预后。
Liver Transpl. 2024 Dec 1;30(12):1273-1280. doi: 10.1097/LVT.0000000000000438. Epub 2024 Jul 17.

本文引用的文献

1
Association of operative time and approach on postoperative complications for esophagectomy.手术时间和手术入路与食管癌术后并发症的关系。
Surgery. 2024 Oct;176(4):1106-1114. doi: 10.1016/j.surg.2024.06.021. Epub 2024 Jul 18.
2
Letter to the Editor: The Hepa 1-6 may not be suitable for use in hepatocellular carcinoma models to explore responses to drug therapy.致编辑的信:Hepa 1-6可能不适用于肝细胞癌模型以探索对药物治疗的反应。
Hepatology. 2024 Apr 1;79(4):E123-E124. doi: 10.1097/HEP.0000000000000733. Epub 2023 Dec 25.
3
m 6 A-mediated gluconeogenic enzyme PCK1 upregulation protects against hepatic ischemia-reperfusion injury.
m6A介导的糖异生酶PCK1上调可保护肝脏免受缺血再灌注损伤。
Hepatology. 2025 Jan 1;81(1):94-110. doi: 10.1097/HEP.0000000000000716. Epub 2023 Dec 12.
4
Outcomes and Risk Factors for Liver Transplantation Using Graft-to-Recipient Weight Ratio Less Than 0.8 Graft From Living Donors: Multicentric Cohort Study.使用来自活体供者的移植物与受者体重比小于 0.8 的移植物进行肝移植的结果和风险因素:多中心队列研究。
Ann Surg. 2024 Jun 1;279(6):1018-1024. doi: 10.1097/SLA.0000000000006104. Epub 2023 Sep 27.
5
Early allograft dysfunction after living donor liver transplantation-current concepts and future directions.活体肝移植后早期移植物功能障碍:现状与未来方向。
Liver Transpl. 2023 Aug 1;29(8):871-884. doi: 10.1097/LVT.0000000000000173. Epub 2023 May 11.
6
Diabetes mellitus and postoperative blood glucose value help predict posthepatectomy liver failure in patients with hepatocellular carcinoma.糖尿病和术后血糖值有助于预测肝细胞癌患者肝切除术后肝衰竭。
J Gastrointest Oncol. 2021 Oct;12(5):2377-2387. doi: 10.21037/jgo-21-491.
7
Prognosis of hypoglycemia episode in cirrhotic patients during hospitalization.肝硬化患者住院期间低血糖发作的预后。
BMC Gastroenterol. 2021 Aug 9;21(1):319. doi: 10.1186/s12876-021-01895-2.
8
Post hepatectomy liver failure (PHLF) - Recent advances in prevention and clinical management.肝切除术后肝功能衰竭(PHLF)——预防和临床管理的新进展。
Eur J Surg Oncol. 2021 Feb;47(2):216-224. doi: 10.1016/j.ejso.2020.09.001. Epub 2020 Sep 10.
9
Comparison of Glucose Loads and Blood Glucose Changes in Patients With and Without Diabetes Mellitus Undergoing Living Donor Liver Transplantation.接受活体供肝移植的糖尿病患者与非糖尿病患者的葡萄糖负荷及血糖变化比较
Transplant Proc. 2020 Jul-Aug;52(6):1794-1797. doi: 10.1016/j.transproceed.2020.01.143. Epub 2020 May 19.
10
Living donor liver transplantation.活体供肝肝移植。
Curr Opin Organ Transplant. 2019 Apr;24(2):131-137. doi: 10.1097/MOT.0000000000000610.